{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:54:10Z","timestamp":1769550850496,"version":"3.49.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-003"],"award-info":[{"award-number":["2022-PUMCH-B-003"]}]},{"name":"the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences","award":["2021\u2043I2M\u20431\u2043002"],"award-info":[{"award-number":["2021\u2043I2M\u20431\u2043002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03699-w","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T16:02:55Z","timestamp":1741795375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary exploration of cell-free DNA in the plasma of patients with parathyroid neoplasms using next-generation sequencing"],"prefix":"10.1186","volume":"25","author":[{"given":"Qingyuan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surong","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"issue":"2","key":"3699_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"Walker MD, Silverberg SJ. Primary hyperparathyroidism. NAT REV ENDOCRINOL. 2018;14(2):115\u201325.","journal-title":"NAT REV ENDOCRINOL"},{"issue":"9","key":"3699_CR2","first-page":"1736","volume":"109","author":"PK Lee","year":"2007","unstructured":"Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. CANCER-AM CANCER SOC. 2007;109(9):1736\u201341.","journal-title":"CANCER-AM CANCER SOC"},{"issue":"7","key":"3699_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4158\/EP-2018-0538","volume":"25","author":"Y Hu","year":"2019","unstructured":"Hu Y, Bi Y, Cui M, Zhang X, Su Z, Wang M, Hua S, Liao Q, Zhao Y, THE INFLUENCE OF SURGICAL EXTENT AND PARAFIBROMIN STAINING ON THE OUTCOME OF PARATHYROID CARCINOMA. 20-YEAR EXPERIENCE FROM A SINGLE INSTITUTE. ENDOCR PRACT. 2019;25(7):634\u201341.","journal-title":"ENDOCR PRACT"},{"key":"3699_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000491039","volume":"51","author":"F Cetani","year":"2019","unstructured":"Cetani F, Pardi E, Marcocci C. Parathyroid carcinoma. FRONT HORM RES. 2019;51:63\u201376.","journal-title":"FRONT HORM RES"},{"issue":"5","key":"3699_CR5","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.amjsurg.2010.09.025","volume":"202","author":"M Schaapveld","year":"2011","unstructured":"Schaapveld M, Jorna FH, Aben KK, Haak HR, Plukker JT, Links TP. Incidence and prognosis of parathyroid gland carcinoma: a population-based study in the Netherlands estimating the preoperative diagnosis. AM J SURG. 2011;202(5):590\u20137.","journal-title":"AM J SURG"},{"issue":"3","key":"3699_CR6","first-page":"378","volume":"86","author":"AR Shaha","year":"1999","unstructured":"Shaha AR, Shah JP. Parathyroid carcinoma: a diagnostic and therapeutic challenge. CANCER-AM CANCER SOC. 1999;86(3):378\u201380.","journal-title":"CANCER-AM CANCER SOC"},{"issue":"3","key":"3699_CR7","first-page":"600","volume":"31","author":"A Schantz","year":"1973","unstructured":"Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. CANCER-AM CANCER SOC. 1973;31(3):600\u20135.","journal-title":"CANCER-AM CANCER SOC"},{"issue":"1","key":"3699_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","volume":"33","author":"LA Erickson","year":"2022","unstructured":"Erickson LA, Mete O, Juhlin CC, Perren A, Gill AJ. Overview of the 2022 WHO classification of parathyroid tumors. ENDOCR PATHOL. 2022;33(1):64\u201389.","journal-title":"ENDOCR PATHOL"},{"issue":"10","key":"3699_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, et al. The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA SURG. 2016;151(10):959\u201368.","journal-title":"JAMA SURG"},{"issue":"1","key":"3699_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12020-020-02535-7","volume":"72","author":"J Wang","year":"2021","unstructured":"Wang J, Wang Q, Zhao T, Liu X, Bai G, Xin Y, Shen H, Wei B. Expression profile of serum-related exosomal miRNAs from parathyroid tumor. Endocrine. 2021;72(1):239\u201348.","journal-title":"Endocrine"},{"issue":"8","key":"3699_CR11","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1210\/jc.2009-2791","volume":"95","author":"E Cavalier","year":"2010","unstructured":"Cavalier E, Daly AF, Betea D, Pruteanu-Apetrii PN, Delanaye P, Stubbs P, Bradwell AR, Chapelle JP, Beckers A. The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma. J CLIN ENDOCR METAB. 2010;95(8):3745\u20139.","journal-title":"J CLIN ENDOCR METAB"},{"issue":"3","key":"3699_CR12","doi-asserted-by":"publisher","first-page":"E453","DOI":"10.1210\/jc.2013-3730","volume":"99","author":"E Cavalier","year":"2014","unstructured":"Cavalier E, Betea D, Schleck ML, Gadisseur R, Vroonen L, Delanaye P, Daly AF, Beckers A. The third\/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platform. J CLIN ENDOCR METAB. 2014;99(3):E453\u20137.","journal-title":"J CLIN ENDOCR METAB"},{"issue":"2","key":"3699_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1086\/302259","volume":"64","author":"MR Hobbs","year":"1999","unstructured":"Hobbs MR, Pole AR, Pidwirny GN, Rosen IB, Zarbo RJ, Coon H, Heath HR, Leppert M, Jackson CE. Hyperparathyroidism-jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q. AM J HUM GENET. 1999;64(2):518\u201325.","journal-title":"AM J HUM GENET"},{"issue":"1","key":"3699_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2796.2009.02107.x","volume":"266","author":"PJ Newey","year":"2009","unstructured":"Newey PJ, Bowl MR, Thakker RV. Parafibromin\u2013functional insights. J INTERN MED. 2009;266(1):84\u201398.","journal-title":"J INTERN MED"},{"key":"3699_CR15","doi-asserted-by":"publisher","first-page":"e936135","DOI":"10.12659\/AJCR.936135","volume":"23","author":"M Popow","year":"2022","unstructured":"Popow M, Kaszczewska M, Goralska M, Kaszczewski P, Skwarek-Szewczyk A, Chudzinski W, Jazdzewski K, Kolanowska M, Bogdanska M, Starzynska-Kubicka A, et al. Association between Parafibromin expression and Presence of Brown tumors and Jaw tumors in patients with primary hyperparathyroidism: series of cases with review of the literature. AM J CASE REP. 2022;23:e936135.","journal-title":"AM J CASE REP"},{"issue":"3","key":"3699_CR16","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s12020-016-0997-3","volume":"54","author":"Y Hu","year":"2016","unstructured":"Hu Y, Liao Q, Cao S, Gao X, Zhao Y. Diagnostic performance of parafibromin immunohistochemical staining for sporadic parathyroid carcinoma: a meta-analysis. Endocrine. 2016;54(3):612\u20139.","journal-title":"Endocrine"},{"issue":"8","key":"3699_CR17","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41379-019-0252-6","volume":"32","author":"CC Juhlin","year":"2019","unstructured":"Juhlin CC, Nilsson IL, Lagerstedt-Robinson K, Stenman A, Branstrom R, Tham E, Hoog A. Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center. Mod PATHOL. 2019;32(8):1082\u201394.","journal-title":"Mod PATHOL"},{"issue":"4","key":"3699_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/cen.14161","volume":"92","author":"R Zhu","year":"2020","unstructured":"Zhu R, Wang Z, Hu Y. Prognostic role of parafibromin staining and CDC73 mutation in patients with parathyroid carcinoma: a systematic review and meta-analysis based on individual patient data. CLIN ENDOCRINOL. 2020;92(4):295\u2013302.","journal-title":"CLIN ENDOCRINOL"},{"key":"3699_CR19","doi-asserted-by":"crossref","unstructured":"Witteveen JE, Hamdy NA, Dekkers OM, Kievit J, van Wezel T, Teh BT et al. Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma. Modern Pathol 2011;24(5):688\u2013697.","DOI":"10.1038\/modpathol.2010.236"},{"issue":"4","key":"3699_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1530\/EC-13-0046","volume":"2","author":"F Cetani","year":"2013","unstructured":"Cetani F, Banti C, Pardi E, Borsari S, Viacava P, Miccoli P, Torregrossa L, Basolo F, Pelizzo MR, Rugge M, et al. CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. ENDOCR CONNECT. 2013;2(4):186\u201395.","journal-title":"ENDOCR CONNECT"},{"issue":"3","key":"3699_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41551-021-00837-3","volume":"6","author":"P Song","year":"2022","unstructured":"Song P, Wu LR, Yan YH, Zhang JX, Chu T, Kwong LN, Patel AA, Zhang DY. Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics. NAT BIOMED ENG. 2022;6(3):232\u201345.","journal-title":"NAT BIOMED ENG"},{"issue":"12","key":"3699_CR22","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/clinchem\/hvac153","volume":"68","author":"JS Lee","year":"2022","unstructured":"Lee JS, Han Y, Yun WG, Kwon W, Kim H, Jeong H, Seo MS, Park Y, Cho SI, Kim H, et al. Parallel analysis of pre- and postoperative circulating tumor DNA and matched Tumor tissues in Resectable Pancreatic Ductal Adenocarcinoma: a prospective cohort study. CLIN CHEM. 2022;68(12):1509\u201318.","journal-title":"CLIN CHEM"},{"issue":"1","key":"3699_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13045-022-01355-8","volume":"15","author":"S Wang","year":"2022","unstructured":"Wang S, Li M, Zhang J, Xing P, Wu M, Meng F, Jiang F, Wang J, Bao H, Huang J, et al. Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer. J HEMATOL ONCOL. 2022;15(1):137.","journal-title":"J HEMATOL ONCOL"},{"issue":"4","key":"3699_CR24","first-page":"1659","volume":"61","author":"S Jahr","year":"2001","unstructured":"Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. CANCER RES. 2001;61(4):1659\u201365.","journal-title":"CANCER RES"},{"issue":"9","key":"3699_CR25","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1002\/ijc.33166","volume":"147","author":"Y Hu","year":"2020","unstructured":"Hu Y, Zhang X, Wang O, Bi Y, Xing X, Cui M, Wang M, Tao W, Liao Q, Zhao Y. The genomic profile of parathyroid carcinoma based on whole-genome sequencing. INT J CANCER. 2020;147(9):2446\u201357.","journal-title":"INT J CANCER"},{"issue":"3","key":"3699_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ijc.31948","volume":"144","author":"M Cui","year":"2019","unstructured":"Cui M, Hu Y, Bi Y, Wang W, Wang M, Zhang X, Zhang R, Wang P, Su Z, Gao X, et al. Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas. INT J CANCER. 2019;144(3):525\u201332.","journal-title":"INT J CANCER"},{"key":"3699_CR27","doi-asserted-by":"crossref","unstructured":"Hu Y, Cui M, Chang X, Wang O, Chen T, Xiao J, Wang M, Hua S, Liao Q. Patterns and Predictors of Cervical Lymph Node Metastasis in Parathyroid Carcinoma. CANCERS. 2022;14(16).","DOI":"10.3390\/cancers14164004"},{"issue":"16","key":"3699_CR28","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. The sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"issue":"5","key":"3699_CR29","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, Del AG, Rivas MA, Hanna M, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. NAT GENET. 2011;43(5):491\u20138.","journal-title":"NAT GENET"},{"issue":"11","key":"3699_CR30","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkw227","volume":"44","author":"Z Lai","year":"2016","unstructured":"Lai Z, Markovets A, Ahdesmaki M, Chapman B, Hofmann O, McEwen R, Johnson J, Dougherty B, Barrett JC, Dry JR. VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research. NUCLEIC ACIDS RES. 2016;44(11):e108.","journal-title":"NUCLEIC ACIDS RES"},{"issue":"16","key":"3699_CR31","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. NUCLEIC ACIDS RES. 2010;38(16):e164.","journal-title":"NUCLEIC ACIDS RES"},{"key":"3699_CR32","unstructured":"Garrison E, Marth G. Haplotype-based variant detection from short-read sequencing. 2012."},{"issue":"3","key":"3699_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/gcc.22517","volume":"57","author":"AL Volckmar","year":"2018","unstructured":"Volckmar AL, Sultmann H, Riediger A, Fioretos T, Schirmacher P, Endris V, Stenzinger A, Dietz S. A field guide for cancer diagnostics using cell-free DNA: from principles to practice and clinical applications. GENE CHROMOSOME CANC. 2018;57(3):123\u201339.","journal-title":"GENE CHROMOSOME CANC"},{"key":"3699_CR34","doi-asserted-by":"crossref","unstructured":"Madsen AT, Winther-Larsen A, McCulloch T, Meldgaard P, Sorensen BS. Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients. CANCERS. 2020;12(4).","DOI":"10.3390\/cancers12040947"},{"issue":"7422","key":"3699_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"GR Abecasis","year":"2012","unstructured":"Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422):56\u201365.","journal-title":"Nature"},{"issue":"7616","key":"3699_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O\u2019Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285\u201391.","journal-title":"Nature"},{"issue":"2","key":"3699_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsdottir","year":"2013","unstructured":"Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. BRIEF BIOINFORM. 2013;14(2):178\u201392.","journal-title":"BRIEF BIOINFORM"},{"issue":"3","key":"3699_CR38","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1007\/s12020-024-03687-6","volume":"84","author":"Y Hu","year":"2024","unstructured":"Hu Y, Mo S, Xiao J, Cui M, Zheng Q, Chen T, Chang X, Liao Q. The significance of an immunohistochemical marker-based panel in assisting the diagnosis of parathyroid carcinoma. Endocrine. 2024;84(3):1146\u201353.","journal-title":"Endocrine"},{"issue":"3","key":"3699_CR39","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s12020-021-02825-8","volume":"74","author":"Y Hu","year":"2021","unstructured":"Hu Y, Zhang X, Wang O, Xing X, Cui M, Wang M, Song C, Liao Q. Spectrum of mitochondrial genomic variation in parathyroid neoplasms. Endocrine. 2021;74(3):690\u20137.","journal-title":"Endocrine"},{"key":"3699_CR40","doi-asserted-by":"crossref","unstructured":"Szabo YT, Shirali AS, Meas S, Sarli V, Clemente-Gutierrez UE, Chiang YJ, Silva-Figueroa A, Vodopivec DM, Williams M, Fisher SB et al. Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma? SURGERY. 2024;175(1):193\u2013198.","DOI":"10.1016\/j.surg.2023.07.043"},{"issue":"1","key":"3699_CR41","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13256-016-1078-1","volume":"10","author":"S Rutledge","year":"2016","unstructured":"Rutledge S, Harrison M, O\u2019Connell M, O\u2019Dwyer T, Byrne MM. Acute presentation of a giant intrathyroidal parathyroid adenoma: a case report. J Med Case Rep. 2016;10(1):286.","journal-title":"J Med Case Rep"},{"issue":"1","key":"3699_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12881-017-0445-0","volume":"18","author":"V Guarnieri","year":"2017","unstructured":"Guarnieri V, Seaberg RM, Kelly C, Jean DM, Raphael S, Shuen AY, Baorda F, Palumbo O, Scillitani A, Hendy GN, et al. Large intragenic deletion of CDC73 (exons 4\u201310) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family. BMC MED GENET. 2017;18(1):83.","journal-title":"BMC MED GENET"},{"key":"3699_CR43","doi-asserted-by":"crossref","unstructured":"Mao X, Wu Y, Yu S, Chen J. Genetic Alteration Profiles and Clinicopathological Associations in Atypical Parathyroid Adenoma. INT J GENOMICS. 2021;2021:6666257.","DOI":"10.1155\/2021\/6666257"},{"issue":"9","key":"3699_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J MED GENET. 2003;40(9):657\u201363.","journal-title":"J MED GENET"},{"issue":"12","key":"3699_CR45","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/humu.23337","volume":"38","author":"L Cardoso","year":"2017","unstructured":"Cardoso L, Stevenson M, Thakker RV. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma. HUM MUTAT. 2017;38(12):1621\u201348.","journal-title":"HUM MUTAT"},{"issue":"18","key":"3699_CR46","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. NEW ENGL J MED. 2003;349(18):1722\u20139.","journal-title":"NEW ENGL J MED"},{"issue":"6","key":"3699_CR47","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1158\/1078-0432.CCR-13-2482","volume":"20","author":"GR Oxnard","year":"2014","unstructured":"Oxnard GR, Paweletz CP, Kuang Y, Mach SL, O\u2019Connell A, Messineo MM, Luke JJ, Butaney M, Kirschmeier P, Jackman DM, et al. Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA. CLIN CANCER RES. 2014;20(6):1698\u2013705.","journal-title":"CLIN CANCER RES"},{"issue":"4","key":"3699_CR48","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jinf.2016.07.011","volume":"73","author":"WW Siljan","year":"2016","unstructured":"Siljan WW, Holter JC, Nymo SH, Schjalm C, Muller F, Jenum PA, Husebye E, Ueland T, Aukrust P, Mollnes TE, et al. Circulating cell-free DNA is elevated in community-acquired bacterial pneumonia and predicts short-term outcome. J Infect. 2016;73(4):383\u20136.","journal-title":"J Infect"},{"issue":"4","key":"3699_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"J Wan","year":"2017","unstructured":"Wan J, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, Pacey S, Baird R, Rosenfeld N. Liquid biopsies come of age: towards implementation of circulating tumour DNA. NAT REV CANCER. 2017;17(4):223\u201338.","journal-title":"NAT REV CANCER"},{"issue":"3","key":"3699_CR50","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.celrep.2018.06.055","volume":"24","author":"K Zhuang","year":"2018","unstructured":"Zhuang K, Huang C, Leng L, Zheng H, Gao Y, Chen G, Ji Z, Sun H, Hu Y, Wu D, et al. Neuron-specific menin deletion leads to synaptic dysfunction and cognitive impairment by modulating p35 expression. CELL REP. 2018;24(3):701\u201312.","journal-title":"CELL REP"},{"key":"3699_CR51","doi-asserted-by":"publisher","first-page":"7458386","DOI":"10.1177\/17588359221096878","volume":"14","author":"V Caputo","year":"2022","unstructured":"Caputo V, De Falco V, Ventriglia A, Famiglietti V, Martinelli E, Morgillo F, Martini G, Corte C, Ciardiello D, Poliero L, et al. Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience. THER ADV MED ONCOL. 2022;14:7458386.","journal-title":"THER ADV MED ONCOL"},{"issue":"20","key":"3699_CR52","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1111\/febs.14080","volume":"284","author":"JE Kammenga","year":"2017","unstructured":"Kammenga JE. The background puzzle: how identical mutations in the same gene lead to different disease symptoms. FEBS J. 2017;284(20):3362\u201373.","journal-title":"FEBS J"},{"issue":"4","key":"3699_CR53","doi-asserted-by":"publisher","first-page":"e1006981","DOI":"10.1371\/journal.pcbi.1006981","volume":"15","author":"AL Brown","year":"2019","unstructured":"Brown AL, Li M, Goncearenco A, Panchenko AR. Finding driver mutations in cancer: elucidating the role of background mutational processes. PLOS COMPUT BIOL. 2019;15(4):e1006981.","journal-title":"PLOS COMPUT BIOL"},{"issue":"7","key":"3699_CR54","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/bjc.2017.250","volume":"117","author":"D Sefrioui","year":"2017","unstructured":"Sefrioui D, Blanchard F, Toure E, Basile P, Beaussire L, Dolfus C, Perdrix A, Paresy M, Antonietti M, Iwanicki-Caron I, et al. Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours. BRIT J CANCER. 2017;117(7):1017\u201325.","journal-title":"BRIT J CANCER"},{"issue":"Suppl 8","key":"3699_CR55","doi-asserted-by":"publisher","first-page":"S384","DOI":"10.21037\/atm.2019.12.97","volume":"7","author":"K Sun","year":"2019","unstructured":"Sun K. Clonal hematopoiesis: background player in plasma cell-free DNA variants. ANN TRANSL MED. 2019;7(Suppl 8):S384.","journal-title":"ANN TRANSL MED"},{"issue":"26","key":"3699_CR56","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, Kahler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, Chambert K, Mick E, Neale BM, Fromer M, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. NEW ENGL J MED. 2014;371(26):2477\u201387.","journal-title":"NEW ENGL J MED"},{"issue":"1","key":"3699_CR57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1677\/ERC-09-0134","volume":"17","author":"S Corbetta","year":"2010","unstructured":"Corbetta S, Vaira V, Guarnieri V, Scillitani A, Eller-Vainicher C, Ferrero S, Vicentini L, Chiodini I, Bisceglia M, Beck-Peccoz P, et al. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. ENDOCR-RELAT CANCER. 2010;17(1):135\u201346.","journal-title":"ENDOCR-RELAT CANCER"},{"issue":"6","key":"3699_CR58","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","volume":"35","author":"V Guarnieri","year":"2012","unstructured":"Guarnieri V, Battista C, Muscarella LA, Bisceglia M, de Martino D, Baorda F, Maiello E, D\u2019Agruma L, Chiodini I, Clemente C, et al. CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort. CELL ONCOL. 2012;35(6):411\u201322.","journal-title":"CELL ONCOL"},{"issue":"2","key":"3699_CR59","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.gastro.2016.04.034","volume":"151","author":"AW Berger","year":"2016","unstructured":"Berger AW, Schwerdel D, Costa IG, Hackert T, Strobel O, Lam S, Barth TF, Schroppel B, Meining A, Buchler MW, et al. Detection of hot-spot mutations in circulating cell-free DNA from patients with Intraductal Papillary Mucinous neoplasms of the pancreas. Gastroenterology. 2016;151(2):267\u201370.","journal-title":"Gastroenterology"},{"key":"3699_CR60","doi-asserted-by":"crossref","unstructured":"Berger AW, Schwerdel D, Reinacher-Schick A, Uhl W, Algul H, Friess H, Janssen KP, Konig A, Ghadimi M, Gallmeier E et al. A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer. THERANOSTICS. 2019;9(5):1280\u20131287.","DOI":"10.7150\/thno.29247"},{"issue":"6","key":"3699_CR61","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.beem.2018.11.002","volume":"32","author":"AS Salcuni","year":"2018","unstructured":"Salcuni AS, Cetani F, Guarnieri V, Nicastro V, Romagnoli E, de Martino D, Scillitani A, Cole D. Parathyroid carcinoma. BEST PRACT RES CL EN. 2018;32(6):877\u201389.","journal-title":"BEST PRACT RES CL EN"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03699-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T16:32:17Z","timestamp":1741797137000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03699-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3699"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03699-w","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"11 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Peking Union Medical College Hospital (JS-2054, K2494).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the patients to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}